CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB

Area of Science:

• Oncology
• Pathology
• Gynecologic Oncology

Background:

• Accurate prognostic factors are crucial for managing FIGO stage IB cervical carcinoma.
• The role of CD44v6 expression as a prognostic marker in this patient group requires clarification.

Purpose of the Study:

• To evaluate the prognostic significance of CD44v6 expression in patients with FIGO stage IB cervical carcinoma.
• To determine if CD44v6 can serve as a universally applicable prognostic factor.

Main Methods:

• Retrospective analysis of 178 radically operated FIGO stage IB cervical carcinoma patients.
• Immunohistochemistry (IHC) was used to assess CD44v6 expression.
• Univariate and multivariate analyses were performed to evaluate prognostic factors, including CD44v6, lymph node status, tumor volume, lymphovascular space invasion (LVSI), GOG score, and deep stromal invasion.

Main Results:

• Lymph node status was the most significant prognostic factor for overall survival (OS).
• CD44v6 expression showed a correlation with squamous cell carcinoma (SCC), deep stromal invasion, LVSI, and GOG score.
• CD44v6 expression was not a statistically significant prognostic factor for OS or disease-free interval (DFI) in univariate or multivariate analyses.

Conclusions:

• CD44v6 expression is associated with specific clinicopathological features in FIGO stage IB cervical carcinoma.
• CD44v6 expression does not appear to have prognostic value for OS or DFI in this patient cohort.
• Lymph node status remains a critical prognostic indicator for FIGO stage IB cervical carcinoma.